iiinova — where your digital self keeps evolving

Imperial Prostate @ip-london.bsky.social · 29/04/2025

That’s a wrap on #AUA25 for Team IP! See you in Washington DC for #AUA26! 🇺🇸

Imperial Prostate @ip-london.bsky.social · 29/04/2025

Update of #IP9ATLAS presented by Archana Gopalakrishnan at #AUA25 🇺🇸 This pivotal RCT will evaluate MRI-based surveillance for patients with GG1-2 cancer starting active surveillance Recruitment is open across the UK!

031

Imperial Prostate @ip-london.bsky.social · 29/04/2025

Update of #IP7PACIFIC presented by @ajwlight.bsky.social at #AUA25 🇺🇸 This will be the first trial to provide definitive evidence comparing bpMRI vs mpMRI, alongside fusion vs cognitive biopsy >1200 patients recruited across the UK - watch this space

122

Imperial Prostate @ip-london.bsky.social · 28/04/2025

In further #RAPID data, Chase Ng shows that patients discharged from a pre-biopsy MRI pathway with ASAP or HGPIN do not have a greater risk of subsequent csPCa or treatment than patients discharged without #AUA25 🇺🇸

011

Imperial Prostate @ip-london.bsky.social · 28/04/2025

Pilot results from #IP2ATLANTA on novel cytoreductive treatments to the prostate & mets in de novo mHSPC presented by @londonprostate1.bsky.social #AUA25 🇺🇸 Take home - these treatments are safe and justified Recruitment for the main trial has completed - PFS endpoint to be reported 2027

011

Imperial Prostate @ip-london.bsky.social · 28/04/2025

Building on our #IP8FLUORESCE study is #IB1LaserCOMPLETE - using ex vivo fluoresce confocal microscopy to establish muscle status in TURBT, presented by Archana Gopalakrishnan Recruitment is under way - watch this space for results soon! #AUA25 🇺🇸

031

Imperial Prostate @ip-london.bsky.social · 27/04/2025

@ajwlight.bsky.social presents preliminary validation data on the #TARGET scoring system - good specificity and NPV for detecting GG2+ in-field disease Watch this space for our definitive multi centre validation study! #AUA25 🇺🇸

012

Imperial Prostate @ip-london.bsky.social · 27/04/2025

Excellent podium presentation by our resident Chase Ng on >1200 patients in #RAPID discharged with negative MRI or biopsy Only 1 in 12 developed csPCa & 1 in 20 needed cancer treatment by 5 years More evidence of the oncological efficacy of pre-biopsy MRI! #AUA25 🇺🇸

031

Imperial Prostate @ip-london.bsky.social · 27/04/2025

5yr outcomes following Rezum for >80mL prostates presented by @ajwlight.bsky.social (on behalf of Yan Leung) #AUA25 🇺🇸 Take home message - 3 of 4 patients were free of retreatment by 5 years

012

Imperial Prostate @ip-london.bsky.social · 27/04/2025

Powerful messages from @londonprostate1.bsky.social in the focal therapy plenary crossfire debate Most intermediate risk cases are suitable, focal therapy is very effective, and the functional outcomes are superior. Surgeon training is crucial! #AUA25 🇺🇸

131

Imperial Prostate @ip-london.bsky.social · 27/04/2025

Greetings from Las Vegas! #AUA25 🇺🇸

000

Imperial Prostate @ip-london.bsky.social · 27/04/2025

New publication alert! 🚨 A clinician survey on the current practices within the prostate cancer diagnostic pathway in the United Kingdom - Uma Walters et al (Journal of Clinical Urology) 🔗 doi.org/10.1177/2051...

032

Imperial Prostate @ip-london.bsky.social · 04/04/2025

👀🤏🏽 We're squeezing a few more in! 🚨Registrations for the Imperial Prostate & Focal Therapy Society Masterclass 2025 close at midnight on Sunday 06/04 - secure your spot now before it's too late! ✨ View the agenda 🔗 www.imperialprostatemasterclass.org #IPFTSmasterclass25

imperialprostatemasterclass.org

Imperial Prostate Masterclass

010

Imperial Prostate @ip-london.bsky.social · 02/04/2025

📢 Join us at @IP_London We are recruiting a Clinical Research Fellow to join the #IP13AVIDITY team: RCT evaluating the role of PSMA PET/CT in directing treatment in patients w/ high-risk PCa (closing 15/04) 🔗 www.imperial.ac.uk/jobs/search-... @londonprostate1.bsky.social @connorurol.bsky.social

imperial.ac.uk

Description

Please note that job descriptions are not exhaustive, and you may be asked to take on additional duties that align with the key responsibilities ment...

022

Imperial Prostate @ip-london.bsky.social · 24/03/2025

With presentations from 4 IP trials and multiple other projects, it’s been a fantastic #EAU25 for Imperial Prostate 🇪🇸 See you next year in London for #EAU26! 🇬🇧

021

Imperial Prostate @ip-london.bsky.social · 24/03/2025

#IP2ATLANTA RCT pilot result #EAU25 🇪🇸 🔬 9 in 10 patients have a viable prostate tumour despite ADT+ARTA/Doce 🚦Early signal in prostate cancer mortality for cytoreductive arms 📈 Surgery, radiotherapy or ablation + SABR safe - Recruited (n=433) PFS exp.2027! @connorurol.bsky.social

021

Imperial Prostate @ip-london.bsky.social · 24/03/2025

Building on this morning’s #NeuroSAFE data, @nikhilmayor.bsky.social presents late-breaking results from #IP8FLUORESCE, assessing the diagnostic accuracy of FCM for detecting positive margins intra-op Feasible, quick and good sensitivity and specificity for detecting margins ≥3mm! #EAU25 🇪🇸

052

Imperial Prostate @ip-london.bsky.social · 24/03/2025

Mr Chase Ng presents 5-year follow-up data for patients discharged with negative MRI/biopsy from our #RAPID pathway #EAU25 🇪🇸 1 in 12 were subsequently diagnosed with GG2+ cancer and 1 in 20 needed treatment - this further highlights the efficacy of MRI-based diagnostics!

011

Imperial Prostate @ip-london.bsky.social · 24/03/2025

It’s a big last day at #EAU25 for our team! 🇪🇸 @connorurol.bsky.social - 2x #IP2ATLANTA pilot study results (12:00) Mr Chase Ng - #RAPID 5-yr follow-up for negative biopsy patients (12:05) Mr Nikhil Mayor - #IP8FLUORESCE late breaking results (12:15)

011

Imperial Prostate @ip-london.bsky.social · 23/03/2025

Lastly for Imperial Prostate today @ #EAU25 🇪🇸 is Ms Deepika Reddy in the new technologies & focal therapy in localised PCa session Traditional risk classification strategies developed for radical treatment are not transferrable to focal therapy outcomes. Risk models are in development!

022

Imperial Prostate @ip-london.bsky.social · 23/03/2025

Excellent presentation by Miss Yan Leung on 5-year outcomes after Rezum in >80mL prostates #EAU25 🇪🇸 75% retreatment-free at 5 years and the majority satisfied with their treatment!

032

Imperial Prostate @ip-london.bsky.social · 23/03/2025

And now @londonprostate1.bsky.social presents an update on the #TRANSFORM randomised prostate cancer screening study in the plenary session - recruitment starting later this year to answer some of the biggest questions in screening 📝📈 #EAU25

034

Imperial Prostate @ip-london.bsky.social · 23/03/2025

👀 @IP_London @ #EAU25 today! Real world experience of Rezūm therapy (≥ 80g) - retreatment rates at 5 years follow up - Miss Yan Leung 📍Green Area EGPT1 ⏱️ 15:30 Outcomes of focal HIFU for localised PCa determined by modern risk stratification strategies - Ms Deepika Reddy 📍Green Area Rm3 ⏱️ 17:15

021

Reposted by Imperial Prostate

Imperial Prostate @ip-london.bsky.social · 22/03/2025

📣 Join Clinical Lecturer Mr Martin Connor as he presents the first Imperial Prostate randomised controlled trial - #IP2ATLANTA internal pilot results are out! Live on Monday 12:00 ⏱️ #EAU25 🇪🇸 #CytoreductiveSurgery #SABR #Ablation @connorurol.bsky.social @londonprostate1.bsky.social

032

Imperial Prostate @ip-london.bsky.social · 22/03/2025

032

Reposted by Imperial Prostate

Imperial Prostate @ip-london.bsky.social · 21/03/2025

Is bpMRI non-inferior to mpMRI? Is image-fusion biopsy superior to cognitive biopsy? @nikhilmayor.bsky.social gives an update on the #IP7PACIFIC trial with >1,000 patients recruited so far #EAU25 🇪🇸

0114

Imperial Prostate @ip-london.bsky.social · 21/03/2025

Next up: PhD Fellow @ajwlight.bsky.social presents an update from the multicentre blinded #IP8FLUORESCE study evaluating #ConfocalMicroscopy for margin status in #RadicalProstatectomy - recruitment complete and results out on Monday 24/03 at #EAU25 🇪🇸

043

Imperial Prostate @ip-london.bsky.social · 21/03/2025

Next is Dr Archana Gopalakrishnan discussing the #IP9ATLAS trial For active surveillance, is regular MRI superior to standard care for detecting progression? Recruitment is open and the trial will randomise 1263 patients in 30 centres. Watch this space! #EAU25 🇪🇸

032

Imperial Prostate @ip-london.bsky.social · 21/03/2025

0114

Imperial Prostate @ip-london.bsky.social · 21/03/2025

It’s a big first day at #EAU25 for our clinical trials & PhD fellows! 🚀 Come along at 15:15 to ‘On the horizon: Ongoing trials in urology’ in Green Area Retiro @nikhilmayor.bsky.social presenting #IP7PACIFIC @ajwlight.bsky.social presenting #IP8FLUORESCE Archana Gopalakrishnan presenting #IP9ATLAS

022

Imperial Prostate @ip-london.bsky.social · 14/03/2025

"Is an RCT between Focal Therapy and Standard of Care a Pipe Dream?" — don't miss Professor Caroline Moore tackling this 🔥 topic during #ipftsmasterclass25 Don't miss out, register today! 🎟️🚨 📍 London, UK | 📅 11-12 April 2025 🔗 imperialprostatemasterclass.org

031

Reposted by Imperial Prostate

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 26/02/2025

Prof Hashim Ahmed @londonprostate1.bsky.social at @ip-london.bsky.social designs clinical trials that report meaningful outcomes, ensuring valuable research funds are used to improve understanding of the best #prostatecancer treatments for men. 📙Read more: prostatecanceruk.org/research/res...

064

Imperial Prostate @ip-london.bsky.social · 07/03/2025

Prof. Hashim Ahmed joined Imperial College London as Professor & Chair of Urology 8️⃣ years (1️⃣3️⃣ clinical trials & countless research projects) ago! 🚀💫 🎉 Congratulations @londonprostate1.bsky.social, thank you for continuing to encourage and inspire all of us @imperialcollegeldn.bsky.social

151

Imperial Prostate @ip-london.bsky.social · 28/02/2025

🚀 We are thrilled to announce Assoc. Prof of Urology Andre Abreu as a member of our international faculty! Join us in London on April 11-12, 2025 for the #IPFTSMasterclass25 ✨Don't miss out, view the agenda & register now: imperialprostatemasterclass.org

000

Imperial Prostate @ip-london.bsky.social · 24/02/2025

📢 We are delighted to have Professor Art Rastinehad as a member of our world-leading faculty! 📅 Join us in London on April 11-12, 2025 for the #IPFTSMasterclass25 🎟️ Don't miss out, view the agenda & register now: imperialprostatemasterclass.org 🚀

020

Imperial Prostate @ip-london.bsky.social · 21/02/2025

We were honoured to have Professor Mark Emberton @uclh.bsky.social proctoring our first @imperialnhs.bsky.social IRE (Nanoknife) list yesterday - we couldn’t ask for a better mentor to guide us through! 🎯⚡️

041

Reposted by Imperial Prostate

Imperial Prostate @ip-london.bsky.social · 19/02/2025

📢 We are delighted to have Professor Jonas Hugosson join our esteemed international faculty! 📅 Join us in London on April 11-12, 2025 for the #ipftsmasterclass25 🎟️ Don’t miss out, view the agenda & register now: www.imperialprostatemasterclass.org 🚀

011

Imperial Prostate @ip-london.bsky.social · 19/02/2025

011

Imperial Prostate @ip-london.bsky.social · 14/02/2025

📢 We are honoured to announce Assoc. Prof Rafael Sanchez-Salas as a member of our international faculty! 📅 Join us in London on April 11-12, 2025 for the #IPFTSMasterclass25 🎟️ Don't miss out, view the agenda & register now: www.imperialprostatemasterclass.org 🚀

000

Imperial Prostate @ip-london.bsky.social · 31/01/2025

⌛️ The countdown is on! Early-bird pricing ends at midnight TONIGHT! ⏱️ 🎟️ Don’t miss your chance to save - register now for the Imperial Prostate & Focal Therapy Society Masterclass 2025! #IPFTSmasterclass25 🔗 Check out the agenda & secure your spot: imperialprostatemasterclass.org

041

Imperial Prostate @ip-london.bsky.social · 30/01/2025

📢 We are delighted to have Professor Hashim Hashim as a member of our world-leading faculty! 🔥 Don't miss our 'Holistic Care in Patients with Prostate Cancer' session at #ipftsmasterclass25 🚨 Be quick! Early-bird pricing ends in 2️⃣ days! 💨 www.imperialprostatemasterclass.org

021

Imperial Prostate @ip-london.bsky.social · 29/01/2025

⌛️ Time's almost up! Early-bird pricing ends in 3⃣ days! 🎟️ Register now to secure the best rate for the Imperial Prostate & Focal Therapy Society Masterclass 2025! #ipftsmasterclass25 🏃💨 www.imperialprostatemasterclass.org 11-12 April 2025, London UK

021

Imperial Prostate @ip-london.bsky.social · 28/01/2025

🎯 You don't want to miss Professor Mark Emberton during the Prostate Cancer Diagnosis plenary session at #ipftsmasterclass25! 🔥 ⌛️Time is running out to register at our best rate! Early-bird pricing closes in 4⃣ days! 🎟️ www.imperialprostatemasterclass.org 11-12 April 2025, London UK

031

Imperial Prostate @ip-london.bsky.social · 26/01/2025

⌛️ Time's almost up! 🐦 Don't miss out on early-bird pricing for the Imperial Prostate & Focal Therapy Society Masterclass 2025! Offer ends 31/01 - don't wait! Register now: www.imperialprostatemasterclass.org 11-12 April 2025, London UK #ipftsmasterclass25

031

Imperial Prostate @ip-london.bsky.social · 24/01/2025

📢 We are delighted to have Dr. Lara Rodríguez Sánchez join our esteemed international faculty! 🎯 ⏱️ Time is running out to secure your spot at an Early-Bird rate, ending on 31/01! 💨 www.imperialprostatemasterclass.org 11-12 April 2025, London UK #ipftsmasterclass25

021

Imperial Prostate @ip-london.bsky.social · 23/01/2025

🚀 Congratulations to our Senior Clinical Focal Fellow Simon Huf, signed off as independent to national expert level in focal HIFU & focal cryotherapy. Wishing you all the best! 🇦🇺 @londonprostate1.bsky.social

042

Imperial Prostate @ip-london.bsky.social · 22/01/2025

📈 With almost 3000 RARP, focal HIFU and focal cryotherapy cases since 2017, we're treating more and more patients across the UK every year at Imperial 🎯 Come and join us as our next Focal Therapy Fellow! Apply by January 28: www.jobs.nhs.uk/candidate/jo...

010

Imperial Prostate @ip-london.bsky.social · 21/01/2025

🎯 Join us at Imperial Prostate! We are recruiting a Prostate Focal Senior Clinical Fellow for a six-month post (closing 28/01) Apply now ➡️ www.jobs.nhs.uk/candidate/jo... @londonprostate1.bsky.social

021